Home/ Stocks/ XBIT

XBiotech Inc

XBIT XNAS

$2.27 -0.01 (-0.44%) ▼ 15-min delayed

Open

$2.27

High

$2.29

Low

$2.27

Volume

15.4K

Market Cap

$69.51M

About XBiotech Inc

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 87 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	N/A	$-5,505,000	$-0.18
FY 2025	N/A	$-45,540,000	$-1.49
Q3 2025	$0	$-6,008,000	$-0.20
Q1 2025	$0	$-10,884,000	$-0.36

Related Market News

No specific coverage for XBIT yet. Check out our latest market news or earnings calendar.

Get XBIT Alerts

Stay ahead with breaking news, price alerts, and expert analysis on XBiotech Inc.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.